HBI Deals+Insights / News
Sanofi, the French drugmaker, plans to invest $437.24 million in its Global Capacity Centre (GCC) in Hyderabad, India, by the end of the decade, Reuters reported. China's low costs and speed previously made it a preferred pharma hub, but political factors are now shifting benefits to India.